June 29, 2011
/PRNewswire/ -- Cott Beverages Inc., a subsidiary of Cott Corporation (NYSE: COT; TSX: BCB), the world's largest private label beverage company, and ChromaDex Inc. (OTCBB: CDXC) announced today that the two companies have entered into a licensing and supply agreement for the joint development of a clinically-backed, proprietary ingredient blend to serve the food & beverage, nutraceutical, and cosmetic markets.
"This agreement provides Cott access to ChromaDex's pTeroPure® platform and establishes a relationship with a science-based leader in the nutraceutical industry," remarked
, VP Business Development of the Star PhytoNutrients division of Cott. "We are excited to partner with ChromaDex, a name synonymous with both quality and science, and license its technology as part of our commitment to offering novel, best-in-class ingredients to our customers."
"For ChromaDex, this agreement represents a great opportunity to license our growing portfolio of intellectual property to a recognized market leader in the consumer goods industry," ChromaDex President
commented. "Cott's market presence, distribution strength, consumer experience, and commitment to products with enhanced functionality and health benefits make it an exceptional partner as we continue to commercialize our pipeline of technology."
About Star PhytoNutrients
The Star PhytoNutrients division of Cott Beverages Inc., a subsidiary of Cott Corporation, develops and markets value-added botanical, fruit, antioxidant and highly functional ingredients, specializing in juice concentrates, fruit powders, and fruit extracts for use in food, beverages, nutraceuticals and cosmeceuticals. With a full line of ingredients derived from cranberries, the number one botanical ingredient in
, Star PhytoNutrients has developed proprietary technologies for enhanced product functionality. For more information, please contact
at 716-366-6100, or visit
ChromaDex is an innovative natural products company that provides proprietary, science-based solutions and ingredients to the dietary supplement, food & beverage, cosmetic and pharmaceutical industries. The company has an impressive pipeline of new ingredients, including its pTeroPure® pterostilbene for which it has worldwide, exclusive patent rights.